Imaging
Renal Infarction
- Preliminary Diagnosis: Renal Infarction
-
I. What imaging technique is first-line for this diagnosis?
- II. Describe the advantages and disadvantages of this technique for diagnosing renal infarction.
-
III. What are the contraindications for the first-line imaging technique?
-
IV. What alternative imaging techniques are available?
- V. Describe the advantages and disadvantages of the alternative techniques for diagnosing renal infarction.
-
VI. What are the contraindications for the alternative imaging techniques?
Preliminary Diagnosis: Renal Infarction
I. What imaging technique is first-line for this diagnosis?
CT scan of the abdomen and pelvis with IV contrast.
II. Describe the advantages and disadvantages of this technique for diagnosing renal infarction.
Advantages
Most sensitive and specific imaging modality in detecting and characterizing a renal infarct.
Highly specific in characterizing the primary lesion and detecting any secondary complications, i.e., abscess, hemorrhage, ruptured kidney, and cyst formation.
May guide treatment and therapy.
Characterizes the surrounding soft tissues, osseous structures, and vasculature.
Disadvantages
Exposes patients to ionizing radiation.
III. What are the contraindications for the first-line imaging technique?
CT imaging may be contraindicated in pregnant patients.
IV. What alternative imaging techniques are available?
Gray scale, Color Doppler, and spectrum waveform analysis.
V. Describe the advantages and disadvantages of the alternative techniques for diagnosing renal infarction.
Advantages
Does not expose patients to ionizing radiation.
Highly portable.
Moderately sensitive and moderately specific in characterizing the kidney and kidney vasculature.
Disadvantages
Highly operator dependent.
VI. What are the contraindications for the alternative imaging techniques?
No specific contraindications to ultrasound exist.
Copyright © 2017, 2014 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
ONA Articles
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Shorter Duration of Cryotherapy as Effective as Standard Therapy Prior to HSCT for Multiple Myeloma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
- 9/11 Responders May Have Higher Head and Neck Cancer Risk
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Helping Patients Face the Challenge of Eating Healthy During Cancer Treatment
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- USPSTF Still Recommends Against Pancreatic Cancer Screening
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Genitourinary Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Rare Cancers | Regimens | |
Skin Cancer | Regimens | Drugs |